MAPT and early-onset autosomal dominant Alzheimer disease: This opens new avenues in the treatment of Alzheimer’s disease, since this diet can effectively reduce the accumulation of amyloid-beta and tau proteins (Oliveira et al., 2024), reduce neuroinflammation (Xu et al., 2022), stimulate synaptic plasticity (Di Lucente et al., 2024) and modulate the gut microbiome (Dilmore et al., 2023) among other effects.